Skip to content
DocTIS

DocTIS

Decision on optimal combinatorinal Therapies in IMIDS using Systems approaches

Menu

  • Home
  • The project
    • Consortium
    • Management Structure
    • Work Packages
  • Media
    • News
    • Events
    • Patients
  • Results
  • Contact
  • Member Area

New Scientific Publications from the DOCTIS Project

New Scientific Publications from the DOCTIS Project

The DOCTIS project has recently published several scientific publications that shed light on crucial advancements in single-cell genomics and potential therapeutic strategies for preventing severe COVID-19. One of the publications, titled “Sampling Time-Dependent Artifacts in Single-Cell Genomic Studies,” highlights the

zabala 28 June 202330 June 2023 Research Read more

DOCTIS: Interview with the coordinator

DOCTIS: Interview with the coordinator

“From the knowledge generated by the DOCTIS project we hope to make a leap in the way IMID patients are treated, and improve the long-term quality of life of thousands of patients”, DOCTIS coordinator To promote the activities of the

zabala 9 January 202330 June 2023 Research Read more

Milestones in combinatorial therapies

Milestones in combinatorial therapies

Milestones in combinatorial therapies The Work Package 6 of the DocTIS Project focuses its efforts in evaluating the combinatorial therapies in animal models of the different IMID’s and compare them to the approved monotherapies. To this purpose, the laboratory of

zabala 17 October 202230 June 2023 Research Read more

Drug candidate for severe COVID-19 identified by IMIDomics and VHIR Rheumatology Group selected for NIH clinical trial

Drug candidate for severe COVID-19 identified by IMIDomics and VHIR Rheumatology Group selected for NIH clinical trial

CD80/86 axis blocking agent abatacept, selected among 130 immunomodulators to be tested in ACTIV-1 IM, a large randomized clinical trial on hospitalized COVID-19 patients. The candidate drug will be tested against anti-TNF therapy, CCR2/5 inhibitor and placebo in relation to

doctis.wp 17 November 202017 November 2020 Research No Comments Read more

IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19

While vaccines are being developed to stop the COVID-19 pandemic, there is a major effort to prevent the high mortality associated with COVID-19 hyperinflammation. Researchers from the Vall Hebron Hospital Research Institute and IMIDomics have contributed to this endeavour by

doctis.wp 22 July 202022 July 2020 Research No Comments Read more

Recent Posts

  • New Scientific Publications from the DOCTIS Project
  • DOCTIS: Interview with the coordinator
  • Milestones in combinatorial therapies
  • DOCTIS Symposium Event
  • SAVE THE DATE: DoCTIS consortium organizes symposium “Combination therapies in common diseases: clinical and translational challenges”, October 7, 2021

Archives

  • June 2023
  • January 2023
  • October 2022
  • September 2021
  • July 2021
  • November 2020
  • July 2020
  • January 2020

Categories

  • Meeting
  • Research
  • Sin categoría

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

 

The DoCTIS project has received funding from the European Union’s H2020 reearch and innovation program under grant agreement 848028.

https://ec.europa.eu/

  • Home
  • The project
    • Consortium
    • Management Structure
    • Work Packages
  • Media
    • News
    • Events
    • Patients
  • Results
  • Contact
  • Member Area

Legal

Privacy Policy

Terms of Use

Legal warning

Contact

  • Email: info@doctis.eu
Copyright © 2023 DocTIS. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.
We use cookies on our website to give you the most relevant experience by remembering your preferences. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
SAVE & ACCEPT